Geode Capital Management
LMNL

Geode Capital Management’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Geode Capital Management’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,274
Closed -$7K – 4842
2022
Q4 		$7K Hold
2,274
– – ﹤0.01% 4870
2022
Q3 		$9K Hold
2,274
– – ﹤0.01% 4997
2022
Q2 		$11K Hold
2,274
– – ﹤0.01% 4980
2022
Q1 		$22K Hold
2,274
– – ﹤0.01% 4925
2021
Q4 		$24K Hold
2,274
– – ﹤0.01% 4933
2021
Q3 		$52K Buy
2,274
+844
+59% +$24.3K ﹤0.01% 4776
2021
Q2 		$55K Buy
+1,430
New +$62.3K ﹤0.01% 4647
2020
Q4 		– Sell
-1,329
Closed -$147K – 4296
2020
Q3 		$147K Buy
+1,329
New +$180K ﹤0.01% 3815

Other funds holding LMNL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Geode Capital Management's LMNL Position: Q1 2023 in Review

Geode Capital Management sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2023, closing a stake of 2,274 shares — an estimated $7K sold.

Geode Capital Management first reported a position in LMNL in Q3 2020 and held it in 8 quarters. The position peaked at $147K in Q3 2020. 8 funds tracked by Wall St. Rank hold LMNL as of Q1 2023.

  • Geode Capital Management reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 2,274 Liminal BioSciences Inc. Common Shares shares in Q1 2023, an estimated $7K.
  • Geode Capital Management first reported a position in Liminal BioSciences Inc. Common Shares in Q3 2020 and held it in 8 quarters.
  • Geode Capital Management's Liminal BioSciences Inc. Common Shares position peaked at $147K in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.